GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OrbusNeich Medical Group Holdings Ltd (FRA:Q8T) » Definitions » Net Income Including Noncontrolling Interests

OrbusNeich Medical Group Holdings (FRA:Q8T) Net Income Including Noncontrolling Interests : €37.6 Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is OrbusNeich Medical Group Holdings Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

OrbusNeich Medical Group Holdings's Net Income Including Noncontrolling Interests for the six months ended in Dec. 2024 was €20.0 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2024 was €37.6 Mil.

OrbusNeich Medical Group Holdings Net Income Including Noncontrolling Interests Historical Data

The historical data trend for OrbusNeich Medical Group Holdings's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrbusNeich Medical Group Holdings Net Income Including Noncontrolling Interests Chart

OrbusNeich Medical Group Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial 5.81 -3.93 17.46 41.33 38.05

OrbusNeich Medical Group Holdings Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.87 23.24 18.24 17.53 20.03

OrbusNeich Medical Group Holdings Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €37.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OrbusNeich Medical Group Holdings Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of OrbusNeich Medical Group Holdings's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

OrbusNeich Medical Group Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OrbusNeich Medical Group Holdings Ltd (FRA:Q8T) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
HKSE:03600 HKSE:01501 HKSE:01358 HKSE:01120 HKSE:01406 HKSE:01947 HKSE:00907 HKSE:08513 HKSE:00876 HKSE:01134 ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD TSE:4543 OCSE:COLO B XPAR:DIM XSWX:STMN
Traded in Other Exchanges
06929:Hong Kong
Address
3rd Floor, Building 20E, Units 303 and 305, Hong Kong Science Park, Shatin New Town, Hong Kong, HKG
Website
https://www.orbusneich.com
OrbusNeich Medical Group Holdings Ltd is a China-based medical device maker of endovascular interventional instruments with majority reach. Its segment include: Asia Pacific region, except Japan and the PRC (APAC), Europe, Middle East & Africa (EMEA), Japan, The PRC, and United States, of which maximum revenue is derived from APAC.

OrbusNeich Medical Group Holdings Headlines

No Headlines